0 CHECKOUT

PRODUCT FILTERS

REGION

415
383
381
370
370

COUNTRY

366
16
12
12
11

PRICE

25
126
247
880

PUBLISHED

191
211
557
880

PRODUCT TYPE

858
22

Respiratory

Respiratory drugs and is a growing sector of the pharmaceuticals industry, and we have all the information resources that you need to be a leading player in this lucrative market. The publications listed under Research and Markets’ Respiratory category cover all drugs and therapeutics for conditions and diseases relating to the lungs and/or breathing, such as Acute Respiratory Distress Syndrome (ARDS), allergy, asthma, bronchitis, COPD (chronic obstructive pulmonary disease), cystic fibrosis, emphysema, lung disease, pneumonia, sinus infections, sleep apnea and others.

Our reports, books, and subscriptions will provide you with the latest industry news, forecasts, market trends and company profiles of market leaders and niche players including: Accentia Biopharmaceuticals, Aerogen, Aerovance, airPharma, AstraZeneca, Aventis Pharma, Bespak, Boehringer Ingelheim Pharmaceuticals, Cadila Pharmaceuticals, Dr. Reddys Laboratories, EvoGenix, GlaxoSmithKlineInyx, The Merck Generics Group, Novartis AG, Pfizer, Ranbaxy Laboratories, Respironics, Sandoz International, Schering-Plough, etc.

Publications on smoking cessation are listed under the OTC sub-category in the Pharmaceuticals section. Show Less
Read more

Respiratory Care Devices Market by Product (Therapeutic (Ventilator, Mask, PAP Device, Inhaler, Nebulizer), Monitoring (Pulse Oximeter, Capnograph), Diagnostic, Consumables & Accessories) & by End User (Hospital, Home Care) - Global Forecast to 2020

The respiratory care devices market is witnessing considerable growth owing to the high prevalence of respiratory diseases, rapid aging of global population, high prevalence of tobacco smoking, urbanization...

Published:  September 2015
Price:  From

Global Preventive Asthma Drugs Market 2015-2019

About asthma According to the Global Initiative for Asthma, asthma is a chronic disease, which is characterized by wheezing, shortness of breath, chest tightness, and cough over a period of time. The...

Published:  October 2015
Price:  From

Global COPD and Asthma Devices Market - Industry Analysis 2015-2019

About COPD and asthma devices COPD and asthma devices are used for inhalation therapy. These devices convert drug suspensions or solutions into aerosolized particles, assisting in drug delivery in individuals...

Published:  October 2015
Price:  From

Orally Inhaled Bronchodilators to 2022

Asthma and COPD continue to be a health segments that present significant challenges to patients and the caregiver community. Patient adherence with prescribing instructions and treatment protocols...

Published:  April 2015
Price:  From

Asthma Drugs Market in the US 2015-2019

About asthma Asthma is a disease that affects the lungs and is characterized by wheezing, coughing, breathlessness, and chest tightness. It is a chronic ailment of the respiratory tract, which is...

Published:  June 2015
Price:  From

Detailed assessment of CIPLA in Indian Respiratory (Asthma & COPD) Market

Established in 1935, Cipla diversified into respiratory business segment in 1972 with launch of medicinal aerosols. At present, Cipla is one of the largest players in Indian respiratory market with...

Published:  March 2015
Price:  From

Investigation Report on China's Cefuroxime Market, 2010-2019

As the second generation of cephalosporin, cefuroxime features broad antibacterial spectrum, high stability and few adverse effects which ensure its great activity against bacteria. First developed...

Published:  September 2015
Price:  From

Preventive Asthma Drug Market Outlook 2020

Asthma is showing high prevalence worldwide. About 300 Million people are suffering from asthma. This is due to continuously deteriorating air quality, which is causing several allergies. In recent...

Published:  December 2015
Price:  From

Investigation Report on China's Moxifloxacin Market, 2010-2019

As the fourth generation of quinolones drugs, moxifloxacin (moxifloxacin hodrochloride) was first introduced to the market by The Bayer Group in Sep. 1999. It is utilized in the treatment of adult...

Published:  June 2015
Price:  From

Investigation Report on China's Moxifloxacin Market, 2010-2019

As the fourth generation of quinolones drugs, moxifloxacin (moxifloxacin hodrochloride) was first introduced to the market by The Bayer Group in Sep. 1999. It is utilized in the treatment of adult...

Published:  June 2015
Price:  From

Investigation Report on China's Levofloxacin Market, 2010-2019

In recent years, the market size of antibiotics has exceeded USD 30 billion around the world with the average growth rate being about 8%. In the drug market in China, anti-infectious drug has been the...

Published:  June 2015
Price:  From

Investigation Report on China's Imipenem and Cilastatin Sodium Market, 2010-2019

Coming into being in the 1980s, penem is an unsatured ß-lactam featuring broad spectrum, strong effect and low resistance rate. Actually it is the most potent antibiotic with the broadest antibacterial...

Published:  June 2015
Price:  From

Investigation Report on China's Piperacillin Sodium and Tazobactam Sodium Market, 2010-2019

Piperacillin sodium and tazobactam sodium is the compound drug of piperacillin sodium and tazobactam sodium, the former being semi-synthesized broad-spectrum penicillin while the latter being ß-lactamase...

Published:  June 2015
Price:  From

Investigation Report on China's Budesonide Market, 2010-2019

With the climatic and environmental changes, seasonal asthma has become the main reason for respiratory ailments. According to an epidemiological survey, the incidence of respiratory ailments is 16%...

Published:  June 2015
Price:  From

Investigation Report on China Tiotropium Bromide Market, 2010-2019

In recent years, various allergic diseases demonstrate an increasing trend under the influence of global environmental changes, leading to the occurrence of seasonal cough and asthma in winter and spring....

Published:  June 2015
Price:  From

Investigation Report on China's Methylprednisolone Market, 2010-2019

Ever since the 1990s, steroids have entered its golden age with over 120 varieties being made for application and sales value in the global market increasing by 10%-15% each year. During the process...

Published:  June 2015
Price:  From

Investigation Report on China's Montelukast Market, 2010-2019

More than 300 million people in the world suffer from seasonal asthma to different degrees. The situation is more serious in seriously polluted countries and regions where tobacco consumption is high....

Published:  May 2015
Price:  From

Investigation Report on China's Montelukast Market, 2010-2019

More than 300 million people in the world suffer from seasonal asthma to different degrees. The situation is more serious in seriously polluted countries and regions where tobacco consumption is high....

Published:  May 2015
Price:  From

Investigation Report on China Tiotropium Bromide Market, 2010-2019

In recent years, various allergic diseases demonstrate an increasing trend under the influence of global environmental changes, leading to the occurrence of seasonal cough and asthma in winter and spring....

Published:  June 2015
Price:  From

Inhaled COPD Therapeutics

COPD is not one but a family of conditions, each with its own etiology and treatment challenges Chronic bronchitis is the inflammation and eventual scarring of the lining of the bronchial tubes Oral...

Published:  June 2014
Price:  From
Loading Indicator

Our Clients